[CIS-PAGID] Quick & Dirty Neoantigen?

[Förster-Waldl Elisabeth]

In Austria we like to use vaccination against TBE ( described in Seidel 
et al., Vaccine 2010). Depending on the IG preparation used for therapy 
very low amounts of TBE antibodies will be found in the IVIG and thus a 
rise in TBE antibodies could be attributed to the TBE vaccination.
Best regards
Elisabeth Förster-Waldl

Elisabeth Förster-Waldl, M.D., Assoc. Prof.
Specialist in Pediatrics
Specialist in Immunology
Dept. of Pediatrics & Juvenile Medicine
Medical University of Vienna
Währinger Gürtel 18-20
A-1090 Vienna
elisabeth.foerster-waldl at meduniwien.ac.at

On Wed, 10 Aug 2011 16:05:56 -0400, Brian P Vickery wrote:

> I follow a medically complex young man with vasculitis and

> hypogammaglobulinemia and for various reasons, completing the

> bacteriophage procedure is probably not feasible. Does anyone have

> experience using another neoantigen in patients on IVIG, ideally one

> that could be done in 4-6 wks? I had heard of folks using Menactra 

> but

> can't find any literature on it (nor in a cursory search, a place to

> titer the antibody). Thought I'd throw it out to the group.

>

> Thanks for any thoughts-

> BPV

> ___________________

>  Brian Vickery, MD

>  Division of Pediatric Allergy & Immunology

>  Duke University Medical Center

>  DUMC Box 2644, Durham NC 27710

>  919.681.2949

>

>  "Email should NOT be used for urgent medical issues. The information

> in this electronic mail is sensitive, protected information intended

> only for the addressee(s). Any other person, including anyone who

> believes he/she might have received it due to an addressing error, is

> requested to notify the sender immediately by return electronic mail,

> and to delete it without further reading or retention. The 

> information

> is not to be forwarded to or shared unless in compliance with Duke

> Medicine policies on confidentiality and/or with the approval of the

> sender."


--